Uromitexan 400 mg/4 ml šķīdums injekcijām Lettland - Lettisch - Zāļu valsts aģentūra

uromitexan 400 mg/4 ml šķīdums injekcijām

baxter latvia, sia, latvia - mesna - Šķīdums injekcijām - 400 mg/4 ml

Finlepsin 400 mg ilgstošās darbības tabletes Lettland - Lettisch - Zāļu valsts aģentūra

finlepsin 400 mg ilgstošās darbības tabletes

teva pharma b.v., netherlands - karbamazepīns - ilgstošās darbības tablete - 400 mg

Avelox 400 mg/250 ml šķīdums infūzijām Lettland - Lettisch - Zāļu valsts aģentūra

avelox 400 mg/250 ml šķīdums infūzijām

bayer ag, germany - moksifloksacīns - Šķīdums infūzijām - 400 mg/250 ml

Maalox 400 mg/400 mg košļājamās tabletes (nesatur cukuru) Lettland - Lettisch - Zāļu valsts aģentūra

maalox 400 mg/400 mg košļājamās tabletes (nesatur cukuru)

opella healthcare france s.a.s., france - aluminii hydroxidum, magnija hydroxidum - košļājamā tablete - 400 mg/400 mg

Phezam 400 mg/25 mg cietās kapsulas Lettland - Lettisch - Zāļu valsts aģentūra

phezam 400 mg/25 mg cietās kapsulas

teva b.v., netherlands - piracetamum, cinnarizinum - kapsula, cietā - 400 mg/25 mg

Moloxin 400 mg/250 ml šķīdums infūzijām Lettland - Lettisch - Zāļu valsts aģentūra

moloxin 400 mg/250 ml šķīdums infūzijām

krka, d.d., novo mesto, slovenia - moksifloksacīns - Šķīdums infūzijām - 400 mg/250 ml

Brufen Plus 400 mg/30 mg apvalkotās tabletes Lettland - Lettisch - Zāļu valsts aģentūra

brufen plus 400 mg/30 mg apvalkotās tabletes

viatris healthcare limited, ireland - ibuprofenum, codeini phosphas hemihydricus - apvalkotā tablete - 400 mg/30 mg

Prezista Europäische Union - Lettisch - EMA (European Medicines Agency)

prezista

janssen-cilag international nv - darunavir - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.

Aspirin C 400 mg/240 mg putojošās tabletes Lettland - Lettisch - Zāļu valsts aģentūra

aspirin c 400 mg/240 mg putojošās tabletes

uab bayer, lithuania - skābes acetylsalicylicum, skābes ascorbicum - putojošā tablete - 400 mg/240 mg

Pamecil 1 g pulveris injekciju/infūziju šķīduma pagatavošanai Lettland - Lettisch - Zāļu valsts aģentūra

pamecil 1 g pulveris injekciju/infūziju šķīduma pagatavošanai

medochemie ltd., cyprus - ampicilīns - pulveris injekciju/infūziju šķīduma pagatavošanai - 1 g